ECHA: map of the "chemical universe"

ECHA has published the "chemical universe" map which implements the action plan published in June and which includes approximately 21,000 substances that have been registered.

These substances are included in one of the following categories that indicate the regulatory actions in progress or under consideration on the same:

• Management of regulatory risks in progress: substances with confirmed risks for human health and the environment.
• Management of regulatory risks under consideration: substances that are currently under consideration for the management of regulatory risk (action 1).
• Data generation: substances that require additional information to conclude if further regulatory action is needed.
• No further action is currently proposed: substances for which the authorities have not currently proposed further regulatory action.
• Not yet assigned: substances currently registered under REACH but not yet assigned to any of the above cases.

This categorization serves to help the Authorities to focus their actions.

ECHA will begin with the screening of substances provided for in the Action Plan based on this mapping.

More news

• 08 April 2024

  Chemicals compliance

  BHT: Restrictions in the UK

  On 1 April 2024, The Cosmetic Products (Restriction of Chemical Substances) Regulations 2024 were published in the UK, amending Annex III of the UK Cosmetics Regulations by placing new restrictions on...

• 04 April 2024

  Chemicals compliance

  COSMETICS REGULATION UPDATE: REGULATION 2024/996 PUBLISHED

  On 3 April 2024, Regulation 2024/996 amending Annexes II, III, V and VI of Regulation (EC) No 1223/2009 was published. Below is the list of the amendments: Annex II (prohibited substances): the substance...

• 18 March 2024

  Chemicals compliance

  Regulation 2024/858: Update of Annexes II and III of the Cosmetics Regulation

  On 15 March 2024, Regulation 2024/858 was published, amending Annexes II and III of Regulation 1223/2009 with regard to certain nanomaterials. The following have been added to Annex II (and are therefore...